Research Article

Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer

Table 1

Investigation of mutation count characteristics in metastatic colorectal cancer database (MSKCC, Cancer Cell 2018). Significant values are marked in bold.

ParametersTest for mutation value for mutation countCorrected value for mutation count

Age at diagnosisSpearman value <0.05 value <0.05
SexMann–Whitney value >0.05 value >0.1
First site of metastasisKruskal–Wallis value >0.05 value >0.1
Fraction of genome alteredSpearman value <0.05 value <0.1
Tumor sample histologyMann–Whitney value <0.05 value <0.05
Stage at diagnosisKruskal–Wallis value <0.05 value <0.05
Primary tumor locationMann–Whitney value <0.05 value <0.05
Primary tumor siteKruskal–Wallis value <0.05 value <0.05
MSI scoreSpearman value <0.05 value <0.05
BRCA mutationsMann–Whitney value <0.05 value <0.05

Additional analyses
 BRCA mutations and tumor sample histologyChi-square value <0.05 value <0.05

Stratified mutation count analysis
 BRCA mutations among MCMann–Whitney value <0.05 value <0.05
 BRCA mutations among ACMann–Whitney value <0.05 value <0.05
 Tumor sample histology and BRCA mutationsMann–Whitney value <0.05 value <0.05
 Tumor sample histology and BRCA WTMann–Whitney value <0.05 value <0.05

Threshold for significance after correction for multiple hypotheses was 0.1.